United States· US:63545-612_de985010-5c3f-7e18-e053-2995a90a50d5
Bismuthum Phosphoricum
A medicinal product containing bismuth phosphate, registered in United States by Hahnemann Laboratories, INC..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BISMUTH PHOSPHATE
- Manufacturer
- Hahnemann Laboratories, INC.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc1163545-612-01
- ndc1163545-612-02
- ndc1163545-612-03
- ndc1163545-612-04
- ndc116354561201200 PELLET in 1 VIAL, GLASS (63545-612-01)
- ndc116354561202500 PELLET in 1 VIAL, GLASS (63545-612-02)
- ndc1163545612033000 PELLET in 1 BOTTLE, GLASS (63545-612-03)
- ndc11635456120410000 PELLET in 1 BOTTLE, GLASS (63545-612-04)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bismuth phosphate in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsBismuthum metallicumBoiron
- FranceGRANIONS DE BISMUTH 2 mg/2 ml, solution buvableGRANIONS
- United KingdomAnusol ointmentChurch & Dwight UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Ulcamed
- Bulgaria · Улкамед
- Cyprus · Bischeme, Bismuth Subcitrate Win Medica
- Czechia · Ulcamed
- Estonia · Ulcamed
- Spain · Gastrodenol
- France · Oligosol
- Greece · Bischeme, Bismuth Krka
- Croatia · Ulcamed
- Hungary · Bizmut-Szubcitrát Elpen, Bizmut-Szubcitrát Win Medica
- Lithuania · Ulcamed
- Poland · Ulcamed
- Romania · Ulcamed
- Slovenia · Bizmutov Oksid Krka
- Slovakia · Ulcamed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ae1d4dc2-3591-4c92-a5db-bf9c9e95d267 GET /v1/drugs/ae1d4dc2-3591-4c92-a5db-bf9c9e95d267?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "1",
"substance": "BISMUTH PHOSPHATE",
"productndc": "63545-612",
"dosage_form": "PELLET",
"dea_schedule": null,
"strength_unit": "[hp_M]/1",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about bismuth phosphate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.